How has been the historical performance of Indoco Remedies?
Indoco Remedies experienced significant financial fluctuations, with net sales and operating income declining from March 2024 to March 2025, resulting in a profit after tax of -77.95 Cr. The company faced challenges in profitability and cash flow management, despite an increase in total assets and liabilities.
Answer:The historical performance of Indoco Remedies shows significant fluctuations in key financial metrics over the years.Breakdown:
Indoco Remedies' net sales peaked at 1,817.29 Cr in March 2024 but fell to 1,664.92 Cr in March 2025, reflecting a decline. The total operating income followed a similar trend, decreasing from 1,817.29 Cr in March 2024 to 1,664.92 Cr in March 2025. Raw material costs decreased from 485.01 Cr in March 2024 to 396.27 Cr in March 2025, while employee costs increased from 361.93 Cr to 394.05 Cr in the same period. Operating profit (PBDIT) saw a sharp decline from 254.16 Cr in March 2024 to 104.71 Cr in March 2025, leading to a profit before tax of -74.37 Cr in March 2025, down from 135.80 Cr the previous year. Consequently, the profit after tax also turned negative, dropping to -77.95 Cr in March 2025 from 97.01 Cr in March 2024. Total assets increased to 2,429.91 Cr in March 2025 from 2,144.73 Cr in March 2024, while total liabilities rose to 2,429.91 Cr from 2,144.73 Cr, indicating a growing debt burden. The cash flow from operating activities decreased to 94.00 Cr in March 2025 from 155.00 Cr in March 2024, and the closing cash and cash equivalents slightly declined to 12.00 Cr from 14.00 Cr. Overall, the financial performance of Indoco Remedies in the latest fiscal year indicates challenges, particularly in profitability and cash flow management.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
